Albany - NY, Sept. 21, 2017 --
Hyperbaric oxygen therapy is essentially a non-invasive method to increase the rate of healing of damaged tissues. It entails delivery of pure oxygen to the bloodstream under high-pressure. Availability of an array of hyperbaric oxygen chambers of various designs and sizes is primarily responsible for this market’s steady growth rate.
The global hyperbaric oxygen therapy devices market will likely expand at a CAGR of 7.4% between 2017 and 2025 to become worth US$284.8 mn by 2025 from US$ 150.0 mn in 2016.
Other factors majorly boosting growth in the global hyperbaric oxygen therapy devices market are the growth in elderly population worldwide, the rising instances of acute and chronic wounds, and the increase in diabetic foot ulcers and pressure cases. Further, surging popularity of leisure adventure activities which results in many accidents and their exhaustive use in aesthetics is also proving beneficial for the market.
View Full Report at https://www.transparencymarketresearch.com/hbo-therapy-devices.html
Hyperbaric oxygen therapy devices find maximum use in wound healing these days. “Rise in public awareness about quicker, smoother wound healing process, extensive use of monoplace HBOT chambers in developed countries of the U.S., Canada, and Japan along with in developing countries such as China, Saudi Arabia, and Brazil is a major factor driving growth in the market,” explains the lead analyst of the report. Major hospitals are readily providing the hyperbaric oxygen therapy in order to speed up the wound healing process and for better recovery.
Depending upon the type of products, the global hyperbaric oxygen therapy devices market can be bifurcated into monoplace HBOT devices and multiplace HBOT devices. Among them, the monoplace HBOT devices accounted for about 60.1% share in the global market in 2016. Some of the factors leading to its swift uptake are technological progress that bring about smoother and quicker healing of wounds, lower price compared to multiplace chambers, helpful regulatory policies in North America, and patients’ hygiene.
Request to View Sample Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=806
Geographically, the key segments of the global hyperbaric oxygen therapy devices market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America currently leads the market. In 2016, its leading share came to over 32.1%. The market is primarily driven by the U.S. on account of its easy reimbursement policies.
Various strategies are leveraged by success-hungry players in the global hyperbaric oxygen therapy devices market. One of them is the thrust on research and development to come up with new or better products. Their focus is on building cost-effective medical devices that would see greater uptake. Strategic partnerships are also being undertaken by them to diversify product portfolios and gain greater share. Further, companies are shifting their gaze to developing countries that offer lucrative opportunities.
Request to download and view full ToC -
https://www.transparencymarketresearch.com/report-toc/806
Overall, the global hyperbaric oxygen therapy devices market is fragmented in nature on account of the presence of numerous small scale vendors. However, the global market is dominated by a handful of prominent players that have their operations worldwide.
Some of the key players operating in the hyperbaric oxygen therapy devices market are Sechrist Industries, Inc., Perry Baromedical, and Environmental Tectonics Corporation (ETC), HAUX-LIFE-SUPPORT GmbH, IHC Hytech B.V., Oxyheal International and Fink Engineering.
Global Hyperbaric Oxygen Therapy Devices Market Report is available @ US$ 5795
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research State Tower 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



